RFK Jr. Launches Review Of Abortion Pill Safety Risks, Adverse Effects

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has launched an investigation into the risks of the abortion drug mifepristone, the 🏢Daily Caller News Foundation confirmed Thursday.

In a letter to 22 Republican attorneys general dated Sept. 19, reviewed by the DCNF, Kennedy and Food and Drug Administration (FDA) Commissioner Marty Makary said the FDA is conducting “its own review of the evidence, including real-world outcomes and evidence, relating to the safety and efficacy of the drug.”

The attorneys general had urged the FDA in July to reassess the safety of the abortion pill, which now accounts for nearly two-thirds of abortions annually and is increasingly common even in states with restrictions.

“The concerns you have raised in your letter merit close examination. This Administration will ensure that women’s health is properly protected by thoroughly investigating the circumstances under which mifepristone can be safely dispensed,” Kennedy and Makary wrote.

They added that the review was prompted by “the lack of adequate consideration underlying the prior approvals, and by recent studies raising concerns about the safety of mifepristone as currently administered.”